Status:
UNKNOWN
Musculoskeletal Function in Hemophilia
Lead Sponsor:
Christian Medical College, Vellore, India
Conditions:
Hemophilia
Eligibility:
MALE
5-15 years
Brief Summary
Hemophilia, which results from deficiency of factor VIII or IX, is a common hereditary X-linked bleeding disorder affecting up to 10/100,000 population. About 60-70% of them have severe disease (facto...
Detailed Description
3.1 Musculoskeletal function in hemophilia - natural history Severe hemophilia is characterized by recurrent bleeding into large joints and muscles resulting in progressive damage and deformity by th...
Eligibility Criteria
Inclusion
- Severe hemophilia, defined as factor assay showing \<1% activity (assay to be done using standard reagents), between 5-15 years of age
- Be willing to come for evaluation at least once in 6-12 months for 5 years
Exclusion
- Detectable inhibitors by screening tests at recruitment
Key Trial Info
Start Date :
June 1 2004
Trial Type :
OBSERVATIONAL
End Date :
June 1 2009
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00324493
Start Date
June 1 2004
End Date
June 1 2009
Last Update
November 30 2006
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Raul Perez Bianco
Buenos Aires, Buenos Aires F.D., Argentina
2
Margareth Castro Ozelo /
Chagas, Cidade Univrsitaria Zeferino Vaz-Campinas-Sp, Brazil, 13 083 970
3
Elbio A.D' Amico / Jorge
São Paulo, São Paulo, Brazil, 01246 903
4
Magdy EI Ekiaby
Cairo, Cairo Governorate, Egypt